Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Quantum-Si Inc. (QSIAW:NASDAQ), powered by AI.
Quantum-Si Inc. is currently trading at $0.20. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Quantum-Si Inc. on Alpha Lenz.
View Quantum-Si Inc.'s valuation metrics on Alpha Lenz.
“Quantum-Si Inc.'s ROE is -46.5%. Explore profitability and growth together.”
Ask for details →Quantum-Si Inc. is a pioneering company specializing in next-generation semiconductor chip-based proteomics technology. The company is at the forefront of transforming cellular protein analysis, aiming to revolutionize how proteomes are decoded and understood. Quantum-Si's unique approach involves the development of advanced single-molecule protein sequencing tools, which significantly enhance the precision and depth of protein analysis compared to traditional methods. This technology holds profound implications for various sectors, including healthcare, drug development, and biotechnology research, by enabling more accurate biomarker discovery and personalized medicine. The company’s innovative solutions provide researchers and clinicians with critical insights into complex biological processes, potentially accelerating the identification of new therapeutic targets and improving disease diagnosis. As part of the broader life sciences and diagnostics industry, Quantum-Si Inc. plays a pivotal role in the emerging field of proteomics, seeking to expand the capabilities of scientific research and contribute to groundbreaking advancements in human health.
“Quantum-Si Inc.'s ROE is -46.5%. Explore profitability and growth together.”
Ask for details →Quantum-Si Inc. (ticker: QSIAW) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 149 employees.
The current price is $0.199 with a P/E ratio of -x and P/B of -x.
ROE is -46.52% and operating margin is -3996.72%. Annual revenue is $2M.